MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance
Simple Summary
Wilczynski, M.; Kielbik, M.; Senderowska, D.; Krawczyk, T.; Szymanska, B.; Klink, M.; Bieńkiewicz, J.; Romanowicz, H.; Frühauf, F.; Malinowski, A. MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance. Cancers 2020, 12, 2680. https://doi.org/10.3390/cancers12092680
Wilczynski M, Kielbik M, Senderowska D, Krawczyk T, Szymanska B, Klink M, Bieńkiewicz J, Romanowicz H, Frühauf F, Malinowski A. MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance. Cancers. 2020; 12(9):2680. https://doi.org/10.3390/cancers12092680
Chicago/Turabian StyleWilczynski, Milosz, Michal Kielbik, Daria Senderowska, Tomasz Krawczyk, Bozena Szymanska, Magdalena Klink, Jan Bieńkiewicz, Hanna Romanowicz, Filip Frühauf, and Andrzej Malinowski. 2020. "MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance" Cancers 12, no. 9: 2680. https://doi.org/10.3390/cancers12092680